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Blood flow in lower limbs affected by peripheral
vascular disease (PVD) has been studied in the
past.1-2 At rest, the overall volume of blood flow is
not reduced in persons with PVD, when compared
with normal subjects.1 During exercise,3 or when
the effects of exercise are simulated by arterial occlu-
sion and the subsequent reactive hyperemia,1 flow
does not increase to the same extent in persons who
have PVD as it does in control subjects. These find-
ings apply whether flow is measured in the common
femoral artery by means of ultrasound scanning4 or
with plethysmography in the whole limb, but it is
not known how these changes are reflected in deep
venous hemodynamics. It is of interest because arte-
rial and venous disease often coexist, and in PVD the
incidence of venous thrombosis may be increased.5,6
During normal physical activity a series of pumps
in the muscles and the foot provides the primary dri-
ving force of venous flow in the lower limb. While it
is difficult to examine flow patterns during exercise,
certain conclusions may be reached by examining
the recumbent patient. In this situation, deep
venous flow is spontaneous, phasic, and unidirec-
tional.7 With the use of color duplex ultrasound
scanning, veins may be identified and their dimen-
sions may be measured. By analyzing the spectrum
of the Doppler signal, the velocity can be estimated.8
To find out how PVD influences deep venous flow
in the lower limbs, we undertook a prospective con-
trolled study examining flow in the popliteal vein
with color duplex ultrasound scanning.
METHODS
Subjects. Eighty-nine patients who had chronic
PVD and whose symptoms warranted arteriography
were recruited from the vascular clinic: 56 com-
plained of claudication alone, 15 suffered from rest
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Purpose: A prospective controlled study was undertaken to determine how peripheral
vascular disease (PVD) influences flow in the deep veins of the leg.
Methods: Eighty-nine patients with peripheral vascular disease and 35 age-matched con-
trol subjects were studied. The popliteal vein diameter and flow velocity were measured
at rest by means of color duplex ultrasound scanning, and these measurements were
compared with the ankle-brachial pressure index. For 23 subjects, measurements were
also performed during reactive hyperemia and then repeated after venous return from
the foot was prevented by an ankle cuff.
Results: There was a significant correlation between the ankle-brachial pressure index
and the popliteal vein diameter (r = 0.35, P < .001) but a negative correlation between
the ankle-brachial pressure index and venous flow velocity among patients with PVD (r
= –0.24, P = .002). In PVD patients the diameter decreased further in reactive hyper-
emia, whereas it increased in control subjects (P < .001). Preventing venous return from
the foot in PVD patients led to diameter increase at rest and abolished the reduction in
diameter caused by reactive hyperemia. Despite the reduction in diameter during reac-
tive hyperemia, flow velocity increased less in patients with PVD than it did in control
subjects (P = .01).
Conclusion: Chronic tissue ischemia results in constriction of the popliteal vein. This
appears to be an active process related to the washout of humoral factors from ischemic
tissues distally, which leads to an increase in flow velocity. The latter may confer some
protection against the deep vein thrombosis that would otherwise tend to occur with
low venous flow rates. (J Vasc Surg 1999;29:1065-70.)
1065
From the Nuffield Department of Surgery, John Radcliffe
Hospital, Headington, Oxford, United Kingdom.
Presented at the 11th Meeting of the European Chapter of the
International Union of Angiology, Rome, Oct 23-26, 1997.
Reprint requests: Gabor Libertiny, FRCS, Oxford Transplant
Centre, The Churchill, Headington, Oxford, OX3 7LJ, UK.
Copyright © 1999 by the Society for Vascular Surgery and
International Society for Cardiovascular Surgery, North
American Chapter.
0741-5214/99/$8.00 24/1/96869
pain, and 18 had gangrene. Thirty-five control sub-
jects without PVD of similar age who were awaiting
general surgical or orthopedic procedures were also
invited to take part. The median age of patients and
control subjects was 70 (42 to 93) and 68 (45 to 87)
years, respectively. The presence or absence of PVD
was confirmed by the clinical history and measure-
ment of the ankle/brachial index (ABI). Control
subjects with an ABI of 0.9 or less were excluded.9
Twenty-two of the patients with PVD had diabetes,
and 25 patients were treated for hypertension. There
was no diabetes among the control subjects, but 10
did have high blood pressure. All studies were per-
formed before angiographic or surgical intervention.
Approval had been obtained from the Regional
Ethics Committee, and all patients gave their
informed consent.
Color duplex scanning. Ultrasound scanning
took place in the vascular laboratory, where the
ambient temperature was 25°C to 29°C. The equip-
ment used was a Diasonics Gateway 2000 series
ultrasound scanning unit (Diasonics Ultrasound,
Santa Clara, Calif) coupled with a 7-MHz two-
dimensional linear array probe with 4-MHz trans-
mitted frequency for Doppler measurements. With
this equipment, an axial resolution of 0.33 mm
could be achieved. Diameters were measured by
using B-mode imaging. Venous blood flow velocity
was estimated by the computer of the ultrasound
scanner as time averaged peak velocity (TAPV).
TAPV is based on the even insonation method,
where the sample volume of the Doppler probe is
opened to the width of the examined vessel to detect
signals as uniformly as possible from the entire vol-
ume of the blood flow. From the Doppler frequen-
cy shift, the momentary peak flow velocity can be
estimated. This momentary velocity is then integrat-
ed over a period, yielding a “time-averaged” veloci-
ty.10 The Doppler measurements were carried out at
an insonation angle of less than 60 degrees.
Examination technique. Both patients and con-
trol subjects were screened with ultrasound scanning
for deep venous thrombosis, chronic venous insuffi-
ciency, and duplicity of the popliteal vein. The pres-
ence of any of these conditions, as well as incom-
pressibility of the leg arteries detected while measur-
ing the ABI, resulted in exclusion of the subject.
After the screening (ie, after at least 30 minutes of
rest), ankle and brachial pressures were taken and the
ABI was calculated. Then the patients were asked to
turn prone on the examining table, which at this
stage was horizontal, and a pad was placed under the
ankles to flex the knees to approximately 10 degrees.
The popliteal vein was chosen as the target for the
ultrasound measurements because it is a “bottle
neck” area in the lower limb venous circulation and
its anatomical position renders it an easy target for
ultrasound examination. Its assessment was per-
formed at the point proximal to the knee joint where
the vein dives toward the adductor canal.
In all patients and control subjects a mean of
three measurements of the antero-posterior diameter
was recorded, and in 60 limbs the transverse diame-
ter was similarly recorded. TAPV was measured for a
respiratory synchronous cycle on three occasions,
and the average was calculated. The procedure was
then repeated on the other leg. Beside the determi-
nation of these parameters, in three separate sub-
groups further measurements were carried out: (1)
In a subgroup of 13 PVD patients and 10 control
subjects, a 20-cm wide femoral blood pressure cuff
was placed around the thigh and inflated 50 mmHg
above the systolic blood pressure for 2 minutes. After
the cuff was released, the maximum diameter and
TAPV during the first 4 seconds were recorded.
Subject to the patient’s tolerance, this reactive hyper-
emia test was repeated on the other side, in which
case the results from each limb were treated sepa-
rately. (2) In a further subgroup of 8 PVD patients
and 7 control subjects, the resting diameter and
TAPV measurements were repeated after 12-cm
blood pressure cuff wide was placed just proximal to
the ankle and inflated to 80 mmHg in order to pre-
vent venous return from the foot. Three measure-
ments were recorded, and the average was calculated.
(3) In another subgroup of 17 PVD and 7 control
patients, both blood pressure cuffs were used simul-
taneously; the reactive hyperemia test was carried out
while the 12-cm blood pressure cuff was also in place
just proximal to the ankle and inflated to 80 mmHg
to prevent venous return from the foot. Changes in
diameter are expressed as differences (ie, resting val-
ues, measured in the same limb, are subtracted from
measurements taken with the respective blood pres-
sure cuff). At the end of the examination, all patients’
weights and heights were recorded and their body
surface areas were calculated.
Statistical analysis. Measured values were
expressed as median (interquartile range). Measure-
ments from the patient and control groups were
compared with the Mann-Whitney test. Diameter
and TAPV values in different symptomatic groups
were compared with the Kruskal-Wallis H test.
Linear correlation analysis was used, and the result
was expressed as Pearson’s correlation coefficient to
determine the relationship between paired variables.
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More complex relations were analyzed with a multi-
ple correlation model. A P value less than 0.05 was
considered statistically significant.
RESULTS
The ABI of the limbs of PVD patients ranged
from 0 to 1.15, with a median of 0.57, and from
0.92 to 1.35 (median 1.1) in control subjects. With
patients and control subjects at rest, the median
diameter of the popliteal vein was 7.03 mm (range,
6.19 to 7.89 mm) in patients with PVD and 7.6 mm
(range, 6.93 to 8.43 mm) in controls (P < .001).
When limbs rather than patients were taken into
account and grouped according to ABI, this differ-
ence was even more pronounced: in limbs with an
ABI less than 0.9, the median popliteal vein diame-
ter was 6.92 mm (range, 6.12 to 7.71 mm), and in
limbs with an ABI of 0.9 or more, it was 7.65 mm
(range, 6.93 to 8.43 mm; P < .001). There was a sig-
nificant correlation between ABI and the measured
diameter (r = 0.35, P < .001; Fig 1). This correlation
remained significant when age and body surface area
were accounted for in analysis of multiple correla-
tions (P < .001). The horizontal diameter showed a
strong correlation with the antero-posterior diame-
ter regardless of ABI (r = 0.74, P < .001), indicating
that the measured diameter reduction in PVD rep-
resented constriction of the vein rather than a
change of its shape. Resting popliteal vein flow
velocity, estimated as TAPV, did not show a signifi-
cant difference between patients with PVD: 6.42
cm/sec (range, 5.49 to 7.78 cm/sec) and controls:
6.83 cm/sec (range, 5.27 to 7.86; P = .32), but in
limbs with an ABI less than 0.9 velocity was signifi-
cantly higher: 6.67 cm/sec (range, 5.63 to 7.93
cm/sec) than in limbs with an ABI of 0.9 or more:
6.28 cm/sec (range, 5.15 to 7.69 cm/sec; P = .04).
Furthermore, among PVD patients there was a sig-
nificant negative correlation between ABI and
TAPV (r = –0.24, P = .002; Fig 2)—that is, TAPV
increased as the disease became more severe. Fig 3
shows TAPV plotted against popliteal vein diameter
in individual limbs with PVD. There was a signifi-
cant negative correlation between diameter and
velocity, estimated as TAPV (r = –0.37, P < .001).
The diameter of the popliteal vein in patients with
diabetes did not differ significantly from those with-
out diabetes: 7.06 mm (range, 6.27 to 7.73 mm)
versus 7.17 mm (range, 6.40 to 8.10 mm; P = .26).
Excluding measurements obtained in diabetic
patients did not significantly influence the results.
The presence of hypertension similarly did not reflect
in the diameter measurements: 7.13 mm (range,
6.38 to 8.13 mm) versus 7.23 mm (range, 6.63 to
7.93 mm; P = .81). Interestingly, TAPV appeared to
be greater among patients without hypertension:
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Fig 1. Correlation analysis between ankle-brachial pressure index and diameter of the popliteal vein
at rest in all subjects (r = 0.35, P < .001). 
*, Control subjects; s, claudication or asymptomatic leg of patients with PVD; 
s , limbs with rest pain; n , gangrene. 
The difference in diameter among these groups of different symptoms is statistically significant (P < .001).
6.66 cm/sec (range, 5.53 to 7.86 cm/sec) versus
6.03 cm/sec for those with hypertension (range,
4.68 to 7.7 cm/sec), although this difference did not
quite reach statistical significance (P = .057).
During reactive hyperemia the diameter of the
popliteal vein increased in control patients by a
median of 0.22 mm (range, –0.12 to 0.83 mm), but
it decreased by 0.8 mm (range, 0.27 to 1.28 mm) in
patients with PVD (P < .001; Fig 4, a). The degree
of this diameter change was related to ABI (r = 0.64,
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Fig 2. Correlation analysis between ABI and flow velocity estimated as TAPV in the popliteal vein at
rest among patients with PVD (r = –0.24, P = .002). 
s, Claudication or asymptomatic leg of patients with PVD; s , limbs with rest pain; n , gangrene. 
The difference in TAPV among these groups of different symptoms is statistically significant (P = .013).
Fig 3. Scattergram of venous velocity (TAPV) plotted against venous diameter in individual limbs with PVD. 
s, Claudication or asymptomatic leg of patients with PVD; 
s , limbs with rest pain; n , gangrene. 
The difference in TAPV among these groups with different symptoms is statistically significant (P = .002).
P < .001)—the more severe the PVD, the greater
the degree of deep venous constriction. During reac-
tive hyperemia venous flow velocity increased in all
subjects, but to a significantly lesser extent in
patients with PVD: 16.1 cm/sec (range, 13.8 to
20.1 cm/sec) versus 26.1 cm/sec (range, 20.7 to
31.8 cm/sec; P = .003). The degree of this velocity
surge showed significant positive correlation with
ABI (r = 0.44, P = .013).
Placing a blood pressure cuff around the ankle and
inflating it to 80 mmHg to prevent venous return
from the foot at rest reduced flow velocity both in
control subjects and in patients with PVD. The extent
of this velocity reduction was 1.9 cm/sec (range, 0.96
to 2.59 cm/sec) among patients with PVD and 2.33
cm/sec (range, 0.98 to 4.2 cm/sec) among control
subjects (P = .70). At the same time, median popliteal
vein diameter also decreased in control subjects by
0.20 mm (range, 0.10 to 0.28 mm), but it increased
by 0.4 mm (range, 0.07 to 0.63 mm) in patients with
PVD (P = .015; Fig 4, b). This diameter change neg-
atively correlated with ABI (r = –0.54, P = .015). In
reactive hyperemia the popliteal vein constriction that
was observed among patients with PVD was abol-
ished by inflating the blood pressure cuff around the
ankle: there was no significant difference in popliteal
vein diameter between patients with PVD and control
subjects in this setup (P = .35; Fig 4, c).
DISCUSSION
This is the first report on how peripheral arterial
disease influences flow in the venous system. We
chose the popliteal vein as a representative area for
both technical and anatomic reasons. Our observa-
tions indicate that the deep veins of the lower limb
constrict in response to ischemia. The degree of this
constriction is related to the severity of the PVD. The
low value of the correlation coefficient is partly
explained by the fact that the magnitude of the
observations were near the value of the axial resolu-
tion of the ultrasound scanning equipment. During
reactive hyperemia, when the hypoxia has been aug-
mented by the preceding arterial occlusion, the vein
becomes even more contracted. However, both at
rest and in the reactive hyperemia test this venocon-
striction can be reversed by preventing the blood
from returning from the foot, an area where the oxy-
gen tension is lowest in the ischemic limb.
Consequently, some humoral factor related to tissue
ischemia must be involved in producing this veno-
constriction. We have also shown that the degree of
venoconstriction is directly related to the severity of
ischemia as measured by the ABI and therefore, pre-
sumably, the amount of humoral factors produced.
In splanchnic areas veins contract under conditions
of local hypoxia and hypercapnia11,12 as part of the
organism’s complex physiologic response to acute
hypoxia. This is thought to be brought about in part
by the sympathetic nervous system, together with the
direct effects of reduced local oxygen and increased
carbon dioxide tensions.12,13 These then trigger
changes in the endothelial production of nitric oxide
or endothelins,12,14,15 which may be responsible for
the contraction of the vascular smooth muscle. In
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Fig 4. Median popliteal vein diameter changes in control subjects and patients with PVD during the
respective physiologic tests. Shaded columns: controls; empty columns: patients with PVD.
PVD similar mechanisms may play a role in the
observed constriction of lower limb veins as part of
the hemodynamic adaptation to PVD.
We also observed an increase in resting venous
flow velocity among patients with PVD that was
dependent on the severity of the disease. This change
in velocity is the result of the constriction of the veins.
It causes a rise in shear stresses at the venous wall that
may have beneficial effects. The correlation between
ABI and TAPV was significant only if patients with
PVD, but not those in the control group, were
included. Normally venous flow velocity is deter-
mined by means of a large number of factors, and
there are inherent inaccuracies regarding velocity esti-
mation of phasic flow with ultrasound scanning.10
This accounts for the amount of scatter seen in Fig 2
and the value of the correlation coefficient. However,
it appears that in PVD factors related to ischemia pre-
vail; thus, we see velocity increase with worsening
ischemia. During reactive hyperemia venous flow
velocity increases to a lesser extent in patients with
PVD than in control subjects; nevertheless, this
increase is greater than it would be without the
observed venoconstriction in reactive hyperemia. 
Reduced venous flow has long been considered
to be an important factor in the development of
venous thrombosis.16 PVD patients, unless involved
in regular walking programs, exercise little, and their
exercise-induced increase in blood flow is impaired,
as is shown by reactive hyperemia tests. As the activ-
ity of their coagulation system is also increased,17 it
is surprising that deep vein thrombosis does not
have a high incidence among them. It is likely that
increased venous blood flow velocity, resulting from
venoconstriction brought about in part by humoral
factors originating from ischemic tissues, has an
important protective role.
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